Standard Chemical & Pharmaceutical Co. Ltd. (TPE:1720)

Market Cap	11.22B
Revenue (ttm)	6.71B
Net Income (ttm)	847.58M
Shares Out	178.70M
EPS (ttm)	4.74
PE Ratio	13.25
Forward PE	n/a
Dividend	2.70 (4.32%)
Ex-Dividend Date	Aug 1, 2024

Volume	252,744
Average Volume	230,175
Open	62.60
Previous Close	62.50
Day's Range	62.60 - 63.00
52-Week Range	60.00 - 79.40
Beta	0.14
RSI	60.14
Earnings Date	Feb 27, 2025

About TPE:1720

Standard Chemical & Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products, supplements, and APIs in Taiwan and internationally. The company offers various pharmaceutical products for metabolic, respiratory, musculoskeletal, digestive, circulatory system, topical dermatological, cardiovascular system, anti-infectives, urogenital system and sex hormones, and others. It engages in processing, manufacturing, and selling of food; and offers western medicine, nourishment, and function food, biochemical nutrition, and ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1967
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 1720

Financial Performance

In 2023, TPE:1720's revenue was 6.24 billion, an increase of 6.64% compared to the previous year's 5.85 billion. Earnings were 834.89 million, an increase of 2.39%.